Next Article in Journal
Cannabis Use in Cancer: A Survey of the Current State at BC Cancer before Recreational Legalization in Canada
Previous Article in Journal
Lessons Learned from a Cancer Knowledge Translation Grants Program: Results of an Evaluation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 26
Issue 4
10.3747/co.26.4853
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Commentary

The Role of Metronomic Chemotherapy in the Era of Cancer Immunotherapy: An Oncologist’s Perspective

by
S.Y. Tsao
Hong Kong Special Administrative Region Cancer Centre, Hong Kong SAR, China
Curr. Oncol. 2019, 26(4), 422-424; https://doi.org/10.3747/co.26.4853
Submission received: 3 May 2019 / Revised: 11 June 2019 / Accepted: 9 July 2019 / Published: 1 August 2019

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Metronomic chemotherapy (MCTX) encompasses a set of chemotherapy (CTX) doses significantly below the conventional maximum tolerated dose (MTD) and delivered largely continually (without the prolonged drug-free breaks typical of MTD CTX). [...]

Share and Cite

MDPI and ACS Style

Tsao, S.Y. The Role of Metronomic Chemotherapy in the Era of Cancer Immunotherapy: An Oncologist’s Perspective. Curr. Oncol. 2019, 26, 422-424. https://doi.org/10.3747/co.26.4853

AMA Style

Tsao SY. The Role of Metronomic Chemotherapy in the Era of Cancer Immunotherapy: An Oncologist’s Perspective. Current Oncology. 2019; 26(4):422-424. https://doi.org/10.3747/co.26.4853

Chicago/Turabian Style

Tsao, S.Y. 2019. "The Role of Metronomic Chemotherapy in the Era of Cancer Immunotherapy: An Oncologist’s Perspective" Current Oncology 26, no. 4: 422-424. https://doi.org/10.3747/co.26.4853

APA Style

Tsao, S. Y. (2019). The Role of Metronomic Chemotherapy in the Era of Cancer Immunotherapy: An Oncologist’s Perspective. Current Oncology, 26(4), 422-424. https://doi.org/10.3747/co.26.4853

Article Metrics

Back to TopTop